Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-09-16 17:56:39
Reporting Period:
Filing Date:
Accepted Time:
2015-09-16 17:56:39
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1572552 Asterias Biotherapeutics Inc. AST Biological Products, (No Disgnostic Substances) (2836) 461047971
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187035 Jane Lebkowski 230 Constitution Drive
Menlo Park CA 94025
President Of R&d No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series A Common Stock Disposition 2015-09-15 4,912 $6.00 476 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 30, 2015.